Navigation Links
New Recombinant XYNTHA Now Available for Patients with Hemophilia A
Date:9/8/2008

out XYNTHA.

Wyeth Hemophilia Patient Access Programs

Wyeth works to help patients with hemophilia have ongoing access to their hemophilia therapies. Through its Factor Resource Program, Wyeth provides several services to assist patients experiencing financial hardship or treatment access issues, including the Insurance-Coverage Program, the Patient Assistance Program, and the Wyeth Hemophilia Hotline (1-888-999-2349).

About Hemophilia A

Hemophilia A is a rare, inherited blood-clotting disorder characterized by spontaneous hemorrhages or prolonged bleeding, typically into joints and soft tissue. People with hemophilia A are deficient in a key protein -- factor VIII -- that is vital in the clotting mechanism to prevent bleeding. Most patients with hemophilia A are dependent on factor VIII replacement therapy.

Indication for XYNTHA

XYNTHA Antihemophilic Factor (Recombinant), Plasma/Albumin-Free is indicated for the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A. XYNTHA does not contain von Willebrand factor and, therefore, is not indicated in Von Willebrand's disease.

Important Safety Information for XYNTHA

-- Anaphylaxis and severe hypersensitivity reactions are possible. Patients should be informed of the early signs of hypersensitivity reactions [including hives (rash with itching), generalized urticaria, tightness of the chest, wheezing, hypotension] and anaphylaxis. Patients should be advised to discontinue use of the product and contact their physician if these symptoms occur.

-- Patients should be advised to contact their physician or treatment facility for further treatment and/or assessment if they experience a lack of a clinical response to factor VIII replacement therapy, as this may be a manifestation of an inhibitor.

-- The most common adverse re
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm
2. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
3. Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
4. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Recombinant Human Renin - Crystallographic Grade
7. Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich
8. Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon
9. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
10. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
11. Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  David Hardison, Ph.D., ... by Deloitte , has been elected chairman of ... Consortium, a non-profit working to establish common protocols ... as it relates to electronic health records. ... mission of collaborating with organizations across the research ...
(Date:7/28/2014)... Washington, DC (PRWEB) July 28, 2014 It’s ... their GI Bill benefits to further their post-secondary education are ... says a study released this year. And according to an ... of this shortfall is veteran students’ uninformed choice of college ... , The details of the study: Some 51.7 percent of ...
(Date:7/28/2014)... 2014 Research and Markets has announced ... 2014-2018" report to their offering. ... a technique used to determine the size of a particle ... crucial to analyze the size of particles as it can ... is performed to determine the behavior and nature of a ...
(Date:7/25/2014)... , July 25, 2014 Amgen (NASDAQ: ... Directors today declared a $0.61 per share dividend for ... paid on Sept. 5, 2014, to all stockholders of ... 14, 2014.  About Amgen Amgen is ... suffering from serious illnesses by discovering, developing, manufacturing and ...
Breaking Biology Technology:ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 4Global Particle Size Analysis Market 2014-2018 2Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3
... DIEGO, Dec. 12 Arena Pharmaceuticals,Inc. (Nasdaq: ... and Randall,E. Woods were appointed to its board ... seventh and eighth independent directors and bring,significant financial ... board of directors. Arena,s board also appointed Mr.,Schneider ...
... maintain successful partnerships, patient, recruitment expertise and its ... CINCINNATI, Dec. 12 Kendle (Nasdaq: KNDL ... today,announced it was named "Best CRO" at the ... selected from among leading global CROs by a,distinguished ...
... 12 The Center for Molecular,Medicine (CMM) today announced ... to offer a new test to help guide the ... or "advanced")., The CMM (http://www.cmmdx.org ) is ... physicians as a vital new tool in managing,patients with ...
Cached Biology Technology:Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors 2Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors 3Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip 2Center for Molecular Medicine Among First Labs in Nation to Offer Groundbreaking Test to Aid in Treatment of Colorectal Cancer 2
(Date:7/28/2014)... (July 28, 2014) Rice University researchers are using ... varying flexibility that can be used as microscale models ... that "bead-spring" polymers, introduced as theory in the 1950s, ... required and should be of interest to materials scientists ... work led by Rice chemical and biomolecular engineer Sibani ...
(Date:7/28/2014)... prevent and treat HIV infection has been problematic until ... can arouse as they get rid of the invaders. ... Institute and the National Institutes of Health (NIH) have ... interferons around the time of infection could have ... research appeared in Nature . , Interferons, ...
(Date:7/28/2014)... explorer Roald Amundsen became the first man to reach ... 100 years later, an international team of scientists led ... have proven that air pollution from industrial activities arrived ... collected from widely spaced locations around the Antarctic continent, ... accurate and precise reconstruction to date of lead pollution ...
Breaking Biology News(10 mins):Seeing is bead-lieving 2Interfering with interferon 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3
... Climate change is causing higher air and water temperatures ... have shrunk the geographic region where blue mussels are able ... researchers published in the Journal of Biogeography . ... live along the East Coast as far south as Cape ...
... Einstein College of Medicine of Yeshiva University has been named ... Centers of Excellence in the Basic Biology of Aging. The ... pursuit of basic research into the biology of aging. Einstein,s ... National Institute on Aging. "Einstein has become a leader ...
... A newly formed advisory committee will develop ... environmental and genetic factors related to breast cancer. ... Coordinating Committee (IBCERCC) was established by the National ... with the National Cancer Institute (NCI), to review ...
Cached Biology News:Too hot to handle: Impacts of climate change on mussels 2Einstein designated an NIH Center of Excellence for aging research 2Einstein designated an NIH Center of Excellence for aging research 3Einstein designated an NIH Center of Excellence for aging research 4New breast cancer committee to establish federal research agenda 2New breast cancer committee to establish federal research agenda 3
Human RELT/TNFRSF19L MAb (Clone 238104)...
...
... assay kit measures NOS activity by monitoring ... This assay is simple, sensitive, and specific ... with both crude and purified enzyme preparations. ... for 50 total reactions. Radiolabeled arginine and ...
Human TSLP MAb (Clone 258136)...
Biology Products: